🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India flag India · Delayed Price · Currency is INR
1,202.00
-2.20 (-0.18%)
Nov 18, 2026, 3:28 PM IST

Zydus Lifesciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
41,98250,40045,25538,59519,60344,873
Depreciation & Amortization
19,66613,7058,8687,3456,9657,086
Other Amortization
375375290296262275
Loss (Gain) From Sale of Assets
-39-23-345-169-208-1,110
Asset Writedown & Restructuring Costs
--2,1961776,042-
Loss (Gain) From Sale of Investments
204-292-650-409-483-751
Provision & Write-off of Bad Debts
-903252992061741
Other Operating Activities
-9,183-17,087-3,461-5,343-2,882-25,229
Change in Accounts Receivable
11,884-8,58111,957-7,472-8,485-1,817
Change in Inventory
-15,551-4,124-4,449-204,407-5,255
Change in Accounts Payable
-6,790-7,951735-476-1,708-1,203
Change in Other Net Operating Assets
-1,619-5,5817,116-1,0593,4284,915
Operating Cash Flow
40,58221,16667,81131,96326,88821,045
Operating Cash Flow Growth
-2.07%-68.79%112.16%18.88%27.76%-36.11%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-37,877-33,940-16,937-9,066-10,309-12,026
Sale of Property, Plant & Equipment
287249514237394354
Cash Acquisitions
-19,786-58,793-3,690-7,201--
Divestitures
----400-
Sale (Purchase) of Intangibles
-----1,127
Investment in Securities
-23,436-11,164-50,168-1824,113-28,633
Other Investing Activities
11,16519,955-12,5411,28777629,175
Investing Cash Flow
-69,581-82,961-83,578-14,75215,350-10,003

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-11,89224,020--2,907
Long-Term Debt Issued
-70,710-141,5857,464
Total Debt Issued
45,00682,60224,020141,58510,371
Short-Term Debt Repaid
----3,102-23,064-
Long-Term Debt Repaid
--9,934-147-827-9,960-14,221
Lease Payments
-748-255-147---13
Total Debt Repaid
-14,486-9,934-147-3,929-33,024-14,221
Net Debt Issued (Repaid)
30,52072,66823,873-3,915-31,439-3,850
Repurchase of Common Stock
-11,063---7,250-8,632-
Common Dividends Paid
-1,003-11,063-3,025-6,210-2,671-3,722
Other Financing Activities
-5,326-3,536-895-413-1,262-1,111
Financing Cash Flow
13,12858,06919,953-17,788-44,004-8,683

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
1,3942,108-214-2316686
Miscellaneous Cash Flow Adjustments
12,3531,90216660--259
Net Cash Flow
-2,1242844,138-748-1,7002,186

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
2,705-12,77450,87422,89716,5799,019
Free Cash Flow Growth
-89.34%-122.19%38.11%83.82%-63.03%
Free Cash Flow Margin
0.89%-4.71%21.89%11.71%9.62%5.97%
Free Cash Flow Per Share
2.69-12.7050.5622.6316.328.81
Levered Free Cash Flow
13,830-9,06228,61716,05710,6117,540
Unlevered Free Cash Flow
17,092-6,78029,20116,33211,3958,255
Free Cash Flow After Leases
1,957-13,02950,72722,89716,5799,006

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
5,3263,5368954131,2621,111
Cash Income Tax Paid
14,66215,91018,01912,8585,9206,746
Change in Working Capital
-12,076-26,23715,359-9,027-2,358-3,360